Submit Deal

SURROZEN INC

Summary

Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 154 M

Avg. Deal Size£ 154 M

Market Context

Senior Management

Craig Parker
President and CEO
Roel Nusse
Co-Founder
Harold Varmus
Co-Founder

Sort

citigroup

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 154 M

Total Value

canale communications

pr advisors (1)

1 Shared Deal

1 Opposite

£ 154 M

Total Value

bank of america

HQ - Charlotte

financial advisors (1)

1 Shared Deal

1 Opposite

£ 154 M

Total Value

wilson sonsini goodrich & rosati

HQ - Palo Alto

legal advisors to financial advisors (1)

1 Shared Deal

1 Opposite

£ 154 M

Total Value

goodwin procter

HQ - Boston

legal advisors (1)

1 Shared Deal

1 Opposite

£ 154 M

Total Value

jp morgan

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 154 M

Total Value

cooley

HQ - Palo Alto

legal advisors (1)

1 Shared Deal

1 For

£ 154 M

Total Value

stifel

HQ - St. Louis

financial advisors (1)

1 Shared Deal

1 For

£ 154 M

Total Value

guggenheim partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 154 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy